B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection

Journal of Immunology

Volumn 182, Issue 6, 2009, Pages 3793-3800

  Bhatt, Kamlesh ^a   Uzelac, Aleksandra ^a   Mathur, Sanjeev ^a,b   McBride, Amanda ^a   Potian, Julius ^a   Salgame, Padmini ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOST RESISTANCE; HOST SUSCEPTIBILITY; IMMUNOMODULATION; LUNG; LUNG GRANULOMA; LUNG LESION; LYMPHOCYTIC INFILTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TUBERCULOSIS; WILD TYPE; AEROSOL; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DOSE RESPONSE; GENETIC PREDISPOSITION; GENETICS; GRANULOMA; IMMUNOLOGY; LUNG TUBERCULOSIS; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

B7 ANTIGEN; CD86 ANTIGEN;

AEROSOLS; ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANULOMA; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; SIGNAL TRANSDUCTION; TUBERCULOSIS, PULMONARY;

EID: 65449184947     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802996     Document Type: Article

References (55)

1. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068.
2. Greenfield, E. A., K. A. Nguyen, and V. K. Kuchroo. 1998. CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18: 389-418.
3. Zha, Y., C. Blank, and T. F. Gajewski. 2004. Negative regulation of T-cell function by PD-1. Crit. Rev. Immunol. 24: 229-237.
4. Khoury, S. J., and M. H. Sayegh. 2004. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20: 529-538.
5. Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20: 29-53.
6. Collins, M., V. Ling, and B. M. Carreno. 2005. The B7 family of immune-regulatory ligands. Genome Biol. 6: 223.
7. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
8. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347.
9. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
10. Dong, C., A. E. Juedes, U. A. Temann, S. Shresta, J. P. Allison, N. H. Ruddle, and R. A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409: 97-101.
11. Rottman, J. B., T. Smith, J. R. Tonra, K. Ganley, T. Bloom, R. Silva, B. Pierce, J. C. Gutierrez-Ramos, E. Ozkaynak, and A. J. Coyle. 2001. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2: 605-611.
12. Sporici, R. A., R. L. Beswick, C. von Allmen, C. A. Rumbley, M. Hayden-Ledbetter, J. A. Ledbetter, and P. J. Perrin. 2001. ICOS ligand costimulation is required for T-cell encephalitogenicity. Clin. Immunol. 100: 277-288.
13. Butte, M. J., M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122.
14. Butte, M. J., V. Pena-Cruz, M. J. Kim, G. J. Freeman, and A. H. Sharpe. 2008. Interaction of human PD-L1 and B7-1. Mol. Immunol. 45: 3567-3572.
15. Keir, M. E., and A. H. Sharpe. 2005. The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 204: 128-143.
16. + T cells. Immunol. Rev. 165: 231-247.
17. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 dvelopmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
18. Ranger, A. M., M. P. Das, V. K. Kuchroo, and L. H. Glimcher. 1996. B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int. Immunol. 8: 1549-1560.
19. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181: 1145-1155.
20. Saegusa, K., N. Ishimaru, K. Yanagi, N. Haneji, M. Nishino, M. Azuma, I. Saito, and Y. Hayashi. 2000. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjogren's syndrome (SS) through up-regulated Th2 response. Clin. Exp. Immunol. 119: 354-360.
21. Bagenstose, L. M., R. Class, P. Salgame, and M. Monestier. 2002. B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity. Clin. Exp. Immunol. 127: 12-19.
22. Chang, T. T., C. Jabs, R. A. Sobel, V. K. Kuchroo, and A. H. Sharpe. 1999. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J. Exp. Med. 190: 733-740.
23. Kaye, P. M. 1995. Costimulation and the regulation of antimicrobial immunity. Immunol. Today 16: 423-427.
24. Subramanian, G., J. W. Kazura, E. Pearlman, X. Jia, I. Malhotra, and C. L. King. 1997. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression. J. Immunol. 158: 5914-5920.
25. Liu, Z., Q. Liu, J. Pesce, J. Whitmire, M. J. Ekkens, A. Foster, J. VanNoy, A. H. Sharpe, J. F. Urban, Jr., and W. C. Gause. 2002. Nippostrongylus brasiliensis can induce B7-independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo. J. Immunol. 169: 6959-6968.
26. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Locksley. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 and Th2 effector cells in experimental Leishmaniasis. J. Immunol. 153: 4142-4148.
27. Brown, J. A., R. J. Greenwald, S. Scott, A. N. Schweitzer, A. R. Satoskar, C. Chung, L. R. Schopf, D. van der Woude, J. P. Sypek, and A. H. Sharpe. 2002. T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major. Eur. J. Immunol. 32: 1764-1772.
28. Brown, J. A., R. G. Titus, N. Nabavi, and L. H. Glimcher. 1996. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J. Infect. Dis. 174: 1303-1308.
29. Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159: 635.
30. Jang, S., S. Uematsu, S. Akira, and P. Salgame. 2004. IL-6 and IL-10 induction from dendritic cells in response to Mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J. Immunol. 173: 3392-3397.
31. Kremer, J. M. 2005. Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis. J. Clin. Rheumatol. 11: S55-S62.
32. Kremer, J. M., R. Westhovens, M. Leon, E. Di Giorgio, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I. F. Nuamah, et al. 2003. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. New Engl. J. Med. 349: 1907-1915.
33. Moreland, L. W., R. Alten, F. Van den Bosch, T. Appelboom, M. Leon, P. Emery, S. Cohen, M. Luggen, W. Shergy, I. Nuamah, and J. C. Becker. 2002. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum. 46: 1470-1479.
34. + T cells differ for acute and persistent phases of polyoma virus infection. J. Immunol. 176: 1814-1824.
35. Abrams, J. R., M. G. Lebwohl, C. A. Guzzo, B. V. Jegasothy, M. T. Goldfarb, B. S. Goffe, A. Menter, N. J. Lowe, G. Krueger, M. J. Brown, et al. 1999. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103: 1243-1252.
36. Lazarevic, V., D. J. Yankura, S. J. DiVito, and J. L. Flynn. 2005. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice. Infect. Immun. 73: 2910-2922.
37. Lazarevic, V., A. J. Myers, C. A. Scanga, and J. L. Flynn. 2003. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19: 823-835.
38. Tsai, M. C., S. Chakravarty, G. Zhu, J. Xu, K. Tanaka, C. Koch, J. Tufariello, J. Flynn, and J. Chan. 2006. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell. Microbiol. 8: 218-232.
39. Rhoades, E. R., A. A. Frank, and I. M. Orme. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78: 57-66.
40. Pedrosa, J., B. M. Saunders, R. Appelberg, I. M. Orme, M. T. Silva, and A. M. Cooper. 2000. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68: 577-583.
41. Tan, B. H., C. Meinken, M. Bastian, H. Bruns, A. Legaspi, M. T. Ochoa, S. R. Krutzik, B. R. Bloom, T. Ganz, R. L. Modlin, and S. Stenger. 2006. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J. Immunol. 177: 1864-1871.
42. Seiler, P., P. Aichele, S. Bandermann, A. E. Hauser, B. Lu, N. P. Gerard, C. Gerard, S. Ehlers, H. J. Mollenkopf, and S. H. Kaufmann. 2003. Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur. J. Immunol. 33: 2676-2686.
43. Lohr, J., B. Knoechel, S. Jiang, A. H. Sharpe, and A. K. Abbas. 2003. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4: 664-669.
44. Johnson, C. M., A. M. Cooper, A. A. Frank, and I. M. Orme. 1998. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect. Immun. 66: 1666-1670.
45. Saunders, B. M., A. A. Frank, I. M. Orme, and A. M. Cooper. 2002. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell Immunol. 216: 65-72.
46. Maglione, P. J., J. Xu, and J. Chan. 2007. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J. Immunol. 178: 7222-7234.
47. Varadhachary, A., S. Perdow, C. Hu, M. Ramanarayanan, and P. Salgame. 1997. Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl. Acad. Sci. USA 94: 5778-5783.
48. Hanlon, A., S. Jang, and P. Salgame. 2005. Cbl-b differentially regulates activation-induced apoptosis in T helper 1 and T helper 2 cells. Immunology 116: 507-512.
49. Tufariello, J. M., J. Chan, and J. L. Flynn. 2003. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3: 578-590.
50. Mohan, V. P., C. A. Scanga, K. Yu, H. M. Scott, K. E. Tanaka, E. Tsang, M. M. Tsai, J. L. Flynn, and J. Chan. 2001. Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect. Immun. 69: 1847-1855.
51. Gardam, M. A., E. C. Keystone, R. Menzies, S. Manners, E. Skamene, R. Long, and D. C. Vinh. 2003. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis. 3: 148-155.
52. Bigbee, C. L., D. G. Gonchoroff, G. Vratsanos, S. G. Nadler, H. G. Haggerty, and J. L. Flynn. 2007. Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice. Arthritis Rheum. 56: 2557-2565.
53. Warren, R. M., T. C. Victor, E. M. Streicher, M. Richardson, N. Beyers, N. C. van Pittius, and P. D. van Helden. 2004. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med. 169: 610-614.
54. van Rie, A., R. Warren, M. Richardson, T. C. Victor, R. P. Gie, D. A. Enarson, N. Beyers, and P. D. van Helden. 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. New Engl. J. Med. 341: 1174-1179.
55. Chiang, C. Y., and L. W. Riley. 2005. Exogenous reinfection in tuberculosis. Lancet Infect. Dis. 5: 629-636.